IL6 and hepatocellular carcinoma: Despite its critical role in acute-phase response in the liver [4], IL6 signaling is protective during fibrosis progression [5], but promotes hepatocellular carcinoma (HCC) in response to chemical carcinogens [6] or in obese mice [7] and has been identified as a major factor associated with the sex disparity observed in liver cancer [6].